ABSTRACT
Blinding is a cornerstone of unbiased therapeutic evaluation [1,2]. Blinding refers to keeping key people, such as participants, healthcare providers, and outcome assessors, unaware of the treatment administered or of the true hypothesis of the trial [3,4].
